欧盟CBD食品产品审批
大麻二酚（CBD）领域的法律环境正迅速变化，尤其涉及CBD食品产品。寻求CBD食品相关商业机遇的企业，建议密切关注最新动态。在欧盟范围内，人们对CBD的认知正发生转变，其风险性与应用前景正被重新审视。
欧盟首例：马耳他大麻合法化
随着《大麻负责任使用管理局法》（以下简称“该法”）的批准，马耳他已迎来大麻合法化。这个地中海岛国成为欧盟首个将成人使用大麻合法化的国家。自2018年起，医疗用大麻在马耳他已属合法。1. 目前哪些行为已合法？该法允许种植最多
智利总统大选：大麻产业的双赢局面（某种程度上……）
Chile’s presidential elections are heading to a second round. We’re paying attention for many reasons, not least the fact that the results will have significant implications for cannabis policy, not just in Chile, but in all of Latin America. The winner of the first round was José Antonio Kast, who eked out a victory over
走吧！墨西哥最高法院一致为大麻铺平道路
昨日，墨西哥最高法院裁定《一般卫生法》及《联邦刑法典》中若干条款违宪，因其禁止为非医疗或研究目的种植四氢大麻酚含量≤1%的大麻。法院认定违宪性源于这些条款侵犯了受保护的工作与贸易自由。该裁决延续了法院此前...
突发：德国将合法化成人用大麻
Germany stands to become the next of shockingly few countries that have approved full legalization of adult-use cannabis, joining Canada and Uruguay (and a number of US states. The societal benefits of adult-use legalization in Germany are obvious (and similar to those in the US): an estimated €4.7 billion benefit to the German economy, which includes the cost savings of cannabis-related criminal enforcement and incarceration as well as generated taxes.
大麻证券诉讼案：南区联邦法院驳回加拿大IPO引发的欺诈诉讼
在近期网络研讨会上，我们讨论的大麻行业诉讼趋势之一是：针对大麻企业在融资阶段涉嫌欺诈行为的诉讼案件数量正持续攀升。对多数企业家而言，筹集资金以支持新业务至关重要。同样重要的是确保自身行为合规——
以色列的大麻现状：最新进展
When it comes to medical cannabis, Israel has long been among the leading nations in the world. You can read a post I wrote about Israel’s achievements on that front, both in terms of legality and actual research, here. But despite its deep history with medical cannabis, the country still does not permit legal sales
乌拉圭与拉丁美洲的大麻产业：全球法律与商业播客——马可·阿尔戈塔专访
Listen HERE or stream on Spotify, Apple Podcasts, Amazon Music, Stitcher, or Soundcloud! At Harris Sliwoski, we keep close tabs on what is happening around the world, and we know that our friends and clients do, as well. We are happy to provide this podcast series: Global Law and Business, hosted by international attorneys Fred Rocafort and Jonathan Bench, where we look at